Nul

Investor: DMG Ventures

Nul, a British health tech startup focused on an alcohol reduction platform, has successfully closed a seed funding round, securing £730,000 (equivalent to $1 million). The investment was led by DMG Ventures, the venture arm of Daily Mail and General Trust (DMGT), with additional participation from BYVP and angel investors.Summary of transaction details:Value: £730,000Sector: Health Tech, Digital Health, Alcohol Reduction PlatformAdvisor: Not specifiedKey Entities: Target: Nul; Lead Investor: DMG Ventures; Other Investors: BYVP, Angel backersLocation: UK (Nul is a British startup)Note: This seed funding round will enable Nul to proceed with its full commercial launch and team expansion, aiming to modernize alcohol reduction services through an accessible, discreet, and evidence-based digital health platform. The investment by DMG Ventures underscores a strategic alignment with the increasing demand for innovative solutions in public health and wellness.

Investor: dmg ventures and BYVP

Nul, an innovative alcohol reduction startup, has successfully secured $1 million in a seed funding round. This investment, led by dmg ventures and BYVP, is set to propel Nul's commercial launch across the UK and pave the way for future international expansion, including into the US market. Summary of transaction details: Value: £800,000 (approximate) Sector: HealthTech, Digital Wellbeing Advisor: Not specified Key Entities: Nul (Target), dmg ventures, BYVP (Lead Investors) Location: London, UK Note: This funding round underscores growing investor confidence in digital health platforms that address significant societal challenges through accessible, evidence-based solutions. Nul's unique combination of clinical care, prescription medication, and behavioral support positions it strongly within the evolving telehealth landscape.

Investor: dmg ventures, BYVP